Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Clinical trial NCT02921256 · COMPLETED
Trial details
- NCT number
- NCT02921256
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-11
- Primary completion
- 2020-04-21
- Enrollment
- 363
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.